Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Change in Accured Expenses: 2013-2024

Historic Change in Accured Expenses for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$3.8 million.

  • Armata Pharmaceuticals' Change in Accured Expenses fell 52.67% to -$371,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $144,000, marking a year-over-year increase of 117.18%. This contributed to the annual value of -$3.8 million for FY2024, which is 254.25% down from last year.
  • As of FY2024, Armata Pharmaceuticals' Change in Accured Expenses stood at -$3.8 million, which was down 254.25% from -$1.1 million recorded in FY2023.
  • Armata Pharmaceuticals' Change in Accured Expenses' 5-year high stood at $3.7 million during FY2022, with a 5-year trough of -$3.8 million in FY2024.
  • Its 3-year average for Change in Accured Expenses is -$383,333, with a median of -$1.1 million in 2023.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Change in Accured Expenses surged by 676.48% in 2022, and later slumped by 254.25% in 2024.
  • Yearly analysis of 5 years shows Armata Pharmaceuticals' Change in Accured Expenses stood at -$760,000 in 2020, then surged by 162.11% to $472,000 in 2021, then skyrocketed by 676.48% to $3.7 million in 2022, then plummeted by 128.92% to -$1.1 million in 2023, then crashed by 254.25% to -$3.8 million in 2024.